Highbridge Capital Management’s Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock ARCK Stock Holding History

Highbridge Capital Management’s Portfolio ARCK Stock Details ARCK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-878,317	Closed	-$8.91M	–	645
2022 Q3	$8.91M	Buy	878,317 +211,259	+32%	+$2.13M	0.13%	209
2022 Q2	$6.69M	Buy	667,058 +689	+0.1%	+$6.92K	0.15%	237
2022 Q1	$6.67M	Buy	666,369 +277,668	+71%	+$2.78M	0.16%	197
2021 Q4	$3.89M	Buy	+388,701	New	+$3.85M	0.08%	255

Other funds holding ARCK

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Highbridge Capital Management's ARCK Position: Q4 2022 in Review

Highbridge Capital Management sold out of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) in Q4 2022, closing a stake of 878,317 shares — an estimated $8.91M sold.

Highbridge Capital Management first reported a position in ARCK in Q4 2021 and held it in 4 quarters. The position peaked at $8.91M in Q3 2022. 2 funds tracked by Wall St. Rank hold ARCK as of Q4 2022.

Highbridge Capital Management reported no remaining Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Highbridge Capital Management sold 878,317 Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock shares in Q4 2022, an estimated $8.91M.
Highbridge Capital Management first reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in Q4 2021 and held it in 4 quarters.
Highbridge Capital Management's Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position peaked at $8.91M in Q3 2022.
2 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock as of Q4 2022.

Based on Highbridge Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.